From Google Scholar + [to 22 June 2013]

From Google Scholar & other sources: Selected Journal Articles, Dissertations, Theses, Commentary

Translational Research Insights From Completed HIV Vaccine Efficacy Trials
HV Tieu, M Rolland, SM Hammer, ME Sobieszczyk – JAIDS Journal of Acquired …, 2013
Abstract: The development of a safe and effective HIV vaccine remains a challenge. The modest efficacy seen in the RV144 vaccine trial represented an important milestone for the field. Results from all efficacy studies done to date have generated new information, which…

Preparing for the Unexpected: The Pivotal Role of Social and Behavioral Sciences in Trials of Biomedical HIV Prevention Interventions
BA Koblin, M Andrasik, J Austin – JAIDS Journal of Acquired Immune Deficiency …, 2013
… HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA; and. … For example, recent work within the HIV Vaccine Trials Network (HVTN) provided valuable insight into factors affecting recruitment of MSM and transgender women into HVTN 505…

Herpes Simplex and Herpes Zoster Eye Disease: Presentation and Management at a City Hospital for the Underserved in the United States
ARP Edell, EJ Cohen – Eye & Contact Lens, 2013
… Underuse of the vaccine against HZ is also a major concern, with only 14.4% of eligible patients receiving it as of 2010.10 Ocular herpes simplex is caused by the HSV and affects nearly half a million individuals in the United States….

Childhood pneumonia in developing countries
The Lancet Respiratory Medicine | 18 June 2013
…A large part of the approach to control of pneumococcal pneumonia has depended on vaccination programmes. However, more than 90 individual serotypes of the bacteria exist, and effective immunisation against pneumococcus necessitates neutralisation of the specific capsular polysaccharides that stimulate the immune system and cause lung inflammation. Available vaccines have progressively incorporated more serotypes, focusing on those associated with the greatest disease burden, and whole-cell techniques could provide greater immunogenicity. …More importantly, studies in Finland, USA, and The Gambia have shown greater effectiveness of pneumococcal vaccines than would have been expected based on targeted serotypes.